Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with Low-Volume de Novo Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - December 5, 2024 698 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-1 study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Weekly Cisplatin-Based Chemoradiotherapy Improves RFS and OS, Although Not Statistically Significant,... September 24, 2025 Five Questions With…Jessica, Katie, and Melanie July 21, 2022 Characterisation of KRAS, Including KRAS G12C, Mutations in Gastrointestinal and Metastatic... July 2, 2021 Adjuvant Chemotherapy Customisation Based on ERCC1 and TS mRNA Levels Does... October 6, 2021 Load more HOT NEWS Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre... High-Fat Diet or Diabetes Drug May Enhance Response to Targeted Cancer... What to Know About Peer-Reviewed Cancer Information and Its Role in... NHS lung cancer patients in England to get early access to...
